Windtree Therapeutics, Inc. (WINT)
OTCMKTS
· Delayed Price · Currency is USD
0.0750
+0.0011 (1.49%)
At close: Sep 26, 2025
Windtree Therapeutics Employees
Windtree Therapeutics had 14 employees as of December 31, 2024. The number of employees decreased by 6 or -30.00% compared to the previous year.
Employees
14
Change
-6
Growth
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$1,688,786
Market Cap
2.52M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Windtree Therapeutics News
- 25 days ago - Windtree Therapeutics Stockholders Approve Key Proposals for Revenue and Profit Generation at ... - GuruFocus
- 5 weeks ago - BNB treasury firm plunges 77% after Nasdaq delisting notice - Cointelegraph
- 6 weeks ago - Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025 - GlobeNewsWire
- 2 months ago - Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption - GlobeNewsWire
- 2 months ago - BNB Rebounds to $780 After $520M Windtree Buy Commitment, Shows Signs of Stabilizing - CoinDesk
- 2 months ago - Windtree Therapeutics announces $520M in new funding to amplify cryptocurrency treasury strategy - Seeking Alpha
- 2 months ago - Windtree Therapeutics Announces Up To $520 Million in New Funding to Amplify BNB Cryptocurrency Treasury Strategy - GlobeNewsWire
- 2 months ago - Kraken to Support Biotech Firm Windtrees $200M BNB Treasury Play - CoinDesk